​

Solventum (SOLV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SOLV Stock Forecast

Solventum (SOLV) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $91.22, with a high of $113.00 and a low of $43.00. This represents a 9.93% increase from the last price of $82.98.

$40 $55 $70 $85 $100 $115 High: $113 Avg: $91.22 Low: $43 Last Closed Price: $82.98

SOLV Stock Rating

Solventum stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (72.73%), 2 Hold (18.18%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 2 8 Strong Sell Sell Hold Buy Strong Buy

SOLV Price Target Upside V Benchmarks

TypeNameUpside
StockSolventum9.93%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks12.62%

Price Target Trends

1M3M12M
# Anlaysts81020
Avg Price Target$97.25$91.50$91.95
Last Closing Price$82.98$82.98$82.98
Upside/Downside17.20%10.27%10.81%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 261751115
Jul, 261652115
Jun, 261562-14
May, 261552-13
Apr, 261562-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 06, 2026Stifel Nicolaus$100.00$84.8217.90%20.51%
Aug 06, 2026Patrick WoodUBS$101.00$87.4715.47%21.72%
Aug 06, 2026Mizuho Securities$113.00$87.4729.19%36.18%
Aug 06, 2026KeyBanc$102.00$87.4716.61%22.92%
Aug 06, 2026Ryan ZimmermanBTIG$95.00$87.478.61%14.49%
Jul 28, 2026UBS$95.00$80.4718.06%14.49%
Jul 13, 2026BTIG$91.00$76.7018.64%9.66%
Jul 08, 2026BMO Capital$81.00$75.187.74%-2.39%
Jun 01, 2026Jefferies$43.00$74.95-42.63%-48.18%
May 15, 2026Michael PiccoloWedbush$94.00$74.4226.31%13.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 06, 2026UBSBuyBuyhold
Aug 06, 2026KeyBancOverweightOverweighthold
Aug 06, 2026BTIGBuyBuyhold
Jul 28, 2026UBSNeutralBuyupgrade
Jul 13, 2026BTIGBuyBuyhold
Jul 08, 2026BMO CapitalMarket Performinitialise
May 15, 2026WedbushOutperforminitialise
May 06, 2026UBSNeutralNeutralhold
Apr 27, 2026KeyBancOverweightOverweighthold
Mar 02, 2026UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 $9 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.79$2.77$8.94---
Avg Forecast-$6.59$5.50$5.87$6.19$6.30
High Forecast-$6.62$5.76$6.35$6.26$6.37
Low Forecast-$6.57$5.23$5.29$6.13$6.23
Surprise %--57.97%62.55%---

Revenue Forecast

$8B $8B $8B $8B $9B $9B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.20B$8.25B$8.32B---
Avg Forecast$8.20B$8.23B$8.26B$8.41B$8.48B$8.57B
High Forecast$8.27B$8.31B$8.33B$8.41B$8.48B$8.65B
Low Forecast$8.13B$8.22B$8.22B$8.40B$8.48B$8.50B
Surprise %-0.27%0.76%---

Net Income Forecast

$0 $400M $800M $1B $2B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$479.00M$1.56B---
Avg Forecast-$1.14B$947.53M$1.00B$1.07B$1.09B
High Forecast-$1.14B$993.31M$1.09B$1.08B$1.10B
Low Forecast-$1.13B$901.75M$911.80M$1.06B$1.08B
Surprise %--57.89%64.22%---

SOLV Forecast FAQ

Is Solventum stock a buy?

Solventum stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 2 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Solventum is a favorable investment for most analysts.

What is Solventum's price target?

Solventum's price target, set by 11 Wall Street analysts, averages $91.22 over the next 12 months. The price target range spans from $43 at the low end to $113 at the high end, suggesting a potential 9.93% change from the previous closing price of $82.98.

How does Solventum stock forecast compare to its benchmarks?

Solventum's stock forecast shows a 9.93% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (12.62%).

What is the breakdown of analyst ratings for Solventum over the past three months?

  • August 2026: 6.67% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 6.67% Strong Sell.
  • July 2026: 6.67% Strong Buy, 40.00% Buy, 33.33% Hold, 13.33% Sell, 6.67% Strong Sell.
  • June 2026: 7.14% Strong Buy, 35.71% Buy, 42.86% Hold, 14.29% Sell, 0% Strong Sell.

What is Solventum’s EPS forecast?

Solventum's average annual EPS forecast for its fiscal year ending in December 2026 is $5.87, marking a -34.34% decrease from the reported $8.94 in 2025. Estimates for the following years are $6.19 in 2027, and $6.3 in 2028.

What is Solventum’s revenue forecast?

Solventum's average annual revenue forecast for its fiscal year ending in December 2026 is $8.41B, reflecting a 1.00% increase from the reported $8.32B in 2025. The forecast for 2027 is $8.48B, and $8.57B for 2028.

What is Solventum’s net income forecast?

Solventum's net income forecast for the fiscal year ending in December 2026 stands at $1B, representing a -35.52% decrease from the reported $1.56B in 2025. Projections indicate $1.07B in 2027, and $1.09B in 2028.